Harvoni vs. Epclusa: What Hepatitis C Patients Should Know

For individuals diagnosed with Hepatitis C, understanding treatment options is an important part of recovery. Among the commonly prescribed antiviral medications are Harvoni and Epclusa . Both are proven to be effective in clearing the virus, but there are differences in how they work, who they're best suited for, and how they are used. This guide outlines the key differences to help patients and caregivers make informed choices. How Harvoni and Epclusa Work Harvoni and Epclusa belong to a class of medications called direct-acting antivirals (DAAs). These treatments stop the virus from multiplying in the body, giving the immune system a chance to clear the infection. Harvoni combines ledipasvir and sofosbuvir . It's mainly used to treat genotype 1 of Hepatitis C, which is the most widespread form in many countries. Epclusa combines sofosbuvir and velpatasvir . It's considered a broad-spectrum (pan-genotypic) treatment and can be used for all major genotypes ...